CryoLife Shares Plunge on FDA Order
Reuters
Shares of CryoLife Inc., which collects and freezes human tissue for transplant, tumbled 63% a day after U.S. regulators said they ordered the company to recall and halt sales of most of its processed tissue because of safety concerns.
After being halted early Thursday, shares of CryoLife closed down $3.49 at $2.03 on the NYSE. .
